Analyze Diet
The Journal of veterinary medical science2023; 85(7); 751-754; doi: 10.1292/jvms.23-0158

Assessment of tetanus revaccination regimens in horses not vaccinated in the previous year.

Abstract: A two-dose revaccination against tetanus is recommended for horses over 2 years old in Japan with no history of vaccination in the previous year. Here, the need for two-dose revaccination was evaluated in terms of antibody titers for each vaccine type, namely monovalent or multivalent. There was no difference in antibody titers between one- and two-dose regimens for up to 1 year, except at 8 weeks with the multivalent vaccine, and all horses had sufficient antibody titers for 1 year of tetanus prophylaxis. These results suggest that one-dose revaccination, regardless of the vaccine type, is as effective as two-dose in preventing tetanus for at least 1 year in horses not vaccinated in the previous year.
Publication Date: 2023-06-01 PubMed ID: 37258221PubMed Central: PMC10372253DOI: 10.1292/jvms.23-0158Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research attempts to determine whether one tetanus vaccination shot is as effective as two for horses older than two years, and that haven’t been vaccinated in the past year. The study indicated that, for up to one year, there was no significant difference between the two vaccination methods.

Objective of the Study

  • The main aim of the study was to assess the need for a two-dose revaccination regimen for horses over 2 years old in Japan that haven’t been vaccinated in the prior year.

Methodology

  • The study evaluated the need by comparing antibody titers for each vaccine type. The vaccine types used in the study were monovalent (single antigen) or multivalent (several antigens).
  • Antibody counts were observed for up to 1 year, with a distinction at 8 weeks for the multivalent vaccine.

Key Findings

  • The research found that there wasn’t any significant difference in antibody titers between horses who received one or two vaccine doses for up to 1 year, except for at the eight-week mark with the multivalent vaccine.
  • All the horses studied still had sufficiently high enough antibody titers to get tetanus prophylaxis for 1 year, despite the number of doses.

Conclusion

  • The findings of the study suggest that one-dose revaccination, no matter the type of vaccine used, appears just as effective as two-dose revaccination in preventing tetanus for at least 1 year in horses that hadn’t been vaccinated in the previous year.

Cite This Article

APA
Kinoshita Y, Yamanaka T, Kodaira K, Niwa H, Uchida-Fujii E, Ueno T. (2023). Assessment of tetanus revaccination regimens in horses not vaccinated in the previous year. J Vet Med Sci, 85(7), 751-754. https://doi.org/10.1292/jvms.23-0158

Publication

ISSN: 1347-7439
NlmUniqueID: 9105360
Country: Japan
Language: English
Volume: 85
Issue: 7
Pages: 751-754

Researcher Affiliations

Kinoshita, Yuta
  • Microbiology Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
Yamanaka, Takashi
  • Research Planning and Coordination Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
Kodaira, Kazumichi
  • Racehorse Rehabilitation Center, Fukushima, Japan.
Niwa, Hidekazu
  • Microbiology Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
Uchida-Fujii, Eri
  • Microbiology Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
Ueno, Takanori
  • Microbiology Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.

MeSH Terms

  • Horses
  • Animals
  • Tetanus / prevention & control
  • Tetanus / veterinary
  • Immunization, Secondary / veterinary
  • Tetanus Toxoid
  • Vaccination / veterinary
  • Japan
  • Antibodies, Bacterial
  • Horse Diseases / prevention & control

Conflict of Interest Statement

The authors have no conflicts of interest to declare.

References

This article includes 12 references
  1. Cortese V, Hankins K, Holland R, Syvrud K. Serologic responses of West Nile virus seronegative mature horses to West Nile virus vaccines. J Equine Vet Sci 33: 1101–1105.
  2. de Melo UP, Ferreira C. Clinical findings and response to treatment of 17 cases of tetanus in horses (2012-2021).. Braz J Vet Med 2022;44:e005321.
  3. Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.. Vaccines (Basel) 2022 Mar 4;10(3).
    pmc: PMC8955191pubmed: 35335029doi: 10.3390/vaccines10030398google scholar: lookup
  4. Green SL, Little CB, Baird JD, Tremblay RR, Smith-Maxie LL. Tetanus in the horse: a review of 20 cases (1970 to 1990).. J Vet Intern Med 1994 Mar-Apr;8(2):128-32.
  5. Kendall A, Anagrius K, Gånheim A, Rosanowski SM, Bergström K. Duration of tetanus immunoglobulin G titres following basic immunisation of horses.. Equine Vet J 2016 Nov;48(6):710-713.
    doi: 10.1111/evj.12502pubmed: 26284567google scholar: lookup
  6. Paillot R, Marcillaud Pitel C, D'Ablon X, Pronost S. Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims.. Vaccines (Basel) 2017 Dec 4;5(4).
    pmc: PMC5748612pubmed: 29207516doi: 10.3390/vaccines5040046google scholar: lookup
  7. Popoff MR. Tetanus in animals.. J Vet Diagn Invest 2020 Mar;32(2):184-191.
    doi: 10.1177/1040638720906814pmc: PMC7081504pubmed: 32070229google scholar: lookup
  8. Recknagel S, Snyder A, Brueser B, Schusser GF. Immunization strategies and seroprotection against tetanus in horses in central Germany. Pferdeheilkunde 31: 469–476.
    doi: 10.21836/PEM20150506google scholar: lookup
  9. Team RC. 2022. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/ [accessed on February 22, 2023].
  10. Tosun S, Batirel A, Oluk AI, Aksoy F, Puca E, Bénézit F, Ural S, Nayman-Alpat S, Yamazhan T, Koksaldi-Motor V, Tekin R, Parlak E, Tattevin P, Kart-Yasar K, Guner R, Bastug A, Meric-Koc M, Oncu S, Sagmak-Tartar A, Denk A, Pehlivanoglu F, Sengoz G, Sørensen SM, Celebi G, Baštáková L, Gedik H, Dirgen-Caylak S, Esmaoglu A, Erol S, Cag Y, Karagoz E, Inan A, Erdem H. Tetanus in adults: results of the multicenter ID-IRI study.. Eur J Clin Microbiol Infect Dis 2017 Aug;36(8):1455-1462.
    doi: 10.1007/s10096-017-2954-3pubmed: 28353183google scholar: lookup
  11. van Galen G, Delguste C, Sandersen C, Verwilghen D, Grulke S, Amory H. Tetanus in the equine species: a retrospective study of 31 cases.. Tijdschr Diergeneeskd 2008 Jun 15;133(12):512-7.
    pubmed: 18615902
  12. Wickham H. 2016. ggplot2: Elegant Graphics for Data Analysis. https://ggplot2.tidyverse.org [accessed on February 22, 2023].

Citations

This article has been cited 0 times.